Matching placebo
Matching placebo is a pharmaceutical drug with 315 clinical trials. Currently 41 active trials ongoing. Historical success rate of 85.1%.
Success Metrics
Based on 205 completed trials
Phase Distribution
Phase Distribution
95
Early Stage
114
Mid Stage
94
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
82.0%
205 of 250 finished
18.0%
45 ended early
41
trials recruiting
315
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Phase 1, Multiple Ascending Dose Study to Evaluate HMS1005 in Participants With Type 2 Diabetes
A Study of Barzolvolimab in Patients With Atopic Dermatitis
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG.
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Clinical Trials (315)
A Phase 1, Multiple Ascending Dose Study to Evaluate HMS1005 in Participants With Type 2 Diabetes
A Study of Barzolvolimab in Patients With Atopic Dermatitis
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG.
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
A Study of CDX-0159 in Patients With Eosinophilic Esophagitis
Nutritional Therapy Plus Corticosteroids for Immune Checkpoint Inhibitor-Related Pneumonitis
The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen A: AADvac1
The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen B: LM11A-31
The Bloom Infant Probiotic (BIP) Study
Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled Asthma
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis
Metformin to Attenuate Progressive Respiratory Decline in Idiopathic Pulmonary Fibrosis
Dexmedetomidine Sublingual Film for the Ambulatory Treatment of Hyperadrenergic Autonomic Crisis in Patients With Familial Dysautonomia
A Study of MIL116 in Healthy Participants and Patients With IgA Nephropathy.
A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)
A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria
A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU)
ALN-APOC3 in Adult Participants With Dyslipidemia
Avatrombopag vs. Placebo for CIT in GI Malignancies
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 315